Central Kentucky Research Associates is now known as AMR Lexington

New Name – Same Mission:  To bring better medicines to life!  We make it possible for people to participate in clinical trials that can change the face of medicine.  To learn more about participation in our studies, click here and one of our enrollment specialists will contact you.


Adult Cigarette Smokers

The purpose of this study is to evaluate the abuse liability and characterize product use behavior of the investigational smokeless tobacco alternative nicotine products as compared to your own brand of cigarettes, a marketed long cut smokeless tobacco product and a marketed nicotine gum.

Read more

Ebola Vaccine Study

The purpose of this study is to show lot-to-lot consistency of the vaccine regimen by demonstrating that paired 2-dose vaccine regimens from 3 consecutively manufactured lots of an investigational Ebola vaccine elicit equivalent immune responses.

Read more

Dietary Supplement for Skin Infections Study

The purpose of this study is to assess the supportive role of an investigational dietary supplement when taken by subjects who are also taking previously failed antibiotics to treat an uncomplicated, community-acquired skin infections, including infections due to Methicillin-Resistant staphylococcus aureus (MRSA).

Read more

Celiac Disease Study

The purpose of this study is to evaluate the safety and effectiveness of an investigational, oral drug for celiac disease to see if it can reduce the symptoms of celiac disease (such as abdominal pain, diarrhea, bloating, cramping, and gas) as compared to a placebo.

Read more


The Alliance for Multispecialty Research (AMR) is an industry-leading clinical research company comprised of 16 of the most highly experienced clinical research centers in the United States. 

Founded in 1994, AMR serves as a hub for shared marketing, business development, and best practices for these elite clinical research centers. 

Exclusive membership is determined by rigorous peer review, revenue and quality requirements, geographic location, and therapeutic expertise.


Since its founding, AMR has conducted over 7,000 Phase I-IV clinical trials across a broad range of therapeutic areas. 

Our flexible solutions propel clinical trials from ideas to reality through relationships with industry experts you know and trust! 

To learn more about AMR’s fully integrated network, click here:  www.amrllc.com



Make an appointment and we’ll contact you.